A 6-month randomized, double-blind, placebo-controlled trial of weekly exenatide in adolescents with obesity.

Daniel Weghuber (First author), A Forslund, H Ahlström, A Alderborn, K Bergström, Susanne Brunner (Co-author), Janne Cadamuro (Co-author), I Ciba, M Dahlbom, Verena Heu (Co-author), J Hofmann, H Kristinsson, J Kullberg, A Ladinger, Florian Lagler (Co-author), M Lidström, H Manell, M Meirik, Katharina Mörwald (Co-author), K RoompR Schneider, H Vilén, Kurt Widhalm (Co-author), F Zsoldos, P Bergsten

Research output: Contribution to journalOriginal Article (Journal)peer-review

46 Citations (Web of Science)
Original languageEnglish
Pages (from-to)e12624
JournalPEDIATRIC OBESITY
Volume15
Issue number7
DOIs
Publication statusPublished - 2020

Keywords

  • BODY-MASS INDEX
  • CHILDHOOD OBESITY
  • RECEPTOR
  • PREVENTION
  • AGONISTS
  • THERAPY
  • DISEASE
  • GLP-1
  • FAT

Cite this